Comparative Pharmacology
Head-to-head clinical analysis: MANNITOL 10 IN PLASTIC CONTAINER versus OSMITROL 15 IN WATER.
Peer-Reviewed Evidence
Head-to-head clinical analysis: MANNITOL 10 IN PLASTIC CONTAINER versus OSMITROL 15 IN WATER.
MANNITOL 10% IN PLASTIC CONTAINER vs OSMITROL 15% IN WATER
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Mannitol is an osmotic diuretic that increases plasma osmolarity, drawing water from tissues into the bloodstream and enhancing water excretion by the kidneys. It also reduces intracranial pressure by creating an osmotic gradient across the blood-brain barrier.
Osmotic diuretic; increases plasma osmolality, drawing water from extravascular to intravascular space, thereby reducing intracranial and intraocular pressure.
Adults: 50-100 g intravenously over 30-60 minutes, typically as a 15-25% solution. For reduction of intracranial pressure, 1.5-2 g/kg as a 20% solution IV over 30-60 minutes. For promotion of diuresis, 50-100 g as a 5-25% solution IV.
IV infusion of 50-200 g over 30-60 minutes as a 15% solution; typical adult dose is 1.5-2 g/kg every 6-8 hours.
None Documented
None Documented
Terminal elimination half-life is 0.25–1.5 hours; prolonged in renal impairment (up to 36 hours).
Terminal elimination half-life is approximately 0.25–1.5 hours in patients with normal renal function; prolonged to 24–36 hours in anuria or severe renal impairment.
Renal: >90% as unchanged drug; minimal biliary or fecal excretion.
Primarily renal excretion as unchanged drug; >97% eliminated by glomerular filtration within 24 hours. Minimal biliary/fecal elimination (<3%).
Category A/B
Category C
Osmotic Diuretic
Osmotic Diuretic